These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10741387)

  • 1. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
    White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
    Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked SCID and other defects of cytokine pathways.
    Uribe L; Weinberg KI
    Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID.
    Minegishi Y; Ishii N; Tsuchida M; Okawa H; Sugamura K; Yata J
    Bone Marrow Transplant; 1995 Dec; 16(6):801-6. PubMed ID: 8750273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
    Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
    N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
    Puel A; Ziegler SF; Buckley RH; Leonard WJ
    Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
    Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
    Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
    Carbonara A; Brusco A; Carbonara C
    Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3ε deficiency: need for IgG-substitution 6 years later.
    Fuehrer M; Pannicke U; Schuetz C; Jacobsen EM; Schulz A; Friedrich W; Schwarz K; Hönig M
    Klin Padiatr; 2014 May; 226(3):149-53. PubMed ID: 24515816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
    Puck JM; Pepper AE; Bédard PM; Laframboise R
    J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.
    Stephan V; Wahn V; Le Deist F; Dirksen U; Broker B; Müller-Fleckenstein I; Horneff G; Schroten H; Fischer A; de Saint Basile G
    N Engl J Med; 1996 Nov; 335(21):1563-7. PubMed ID: 8900089
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.
    Ginn SL; Smyth C; Wong M; Bennetts B; Rowe PB; Alexander IE
    Hum Mutat; 2004 May; 23(5):522-3. PubMed ID: 15108287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
    Kume A; Koremoto M; Mizukami H; Okada T; Hanazono Y; Sugamura K; Ozawa K
    Bone Marrow Transplant; 2002 Jul; 30(2):113-8. PubMed ID: 12132050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output.
    Pirovano S; Notarangelo LD; Malacarne F; Mazzolari E; Porta F; Lanfranchi A; Giliani S; Zucca S; Pecorelli S; Albertini A; Ugazio AG; Imberti L
    Haematologica; 2004 Apr; 89(4):450-61. PubMed ID: 15075079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domestic animal models of severe combined immunodeficiency: canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses.
    Felsburg PJ; Somberg RL; Perryman LE
    Immunodefic Rev; 1992; 3(4):277-303. PubMed ID: 1449787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency.
    Bartolomé J; Porta F; Lafranchi A; Rodríguez-Molina JJ; Cela E; Cantalejo A; Fernández-Cruz E; Gómez-Pineda A; Ugazio AG; Notarangelo LD; Gil J
    Bone Marrow Transplant; 2002 Apr; 29(7):625-8. PubMed ID: 11979315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
    Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
    J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
    Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
    Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal IgA gammopathy due to maternal B cells in an infant with severe combined immunodeficiency (SCID) prior to hematopoietic stem cell transplantation.
    Kobrynski LJ; Abramowsky C
    J Pediatr Hematol Oncol; 2006 Jan; 28(1):53-6. PubMed ID: 16394896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive conditioning for severe combined immunodeficiency--help or hindrance?
    Laberko A; Gennery AR
    Expert Rev Clin Immunol; 2015; 11(7):785-8. PubMed ID: 26099343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.